Skip to main content
Journal cover image

Comparison of the risk associated with diabetes mellitus in patients with preserved and low ejection fraction heart failure: An analysis of the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) program

Publication ,  Conference
MacDonald, MR; Varyani, F; Carlsson, J; Petrie, M; Ostergren, J; Michelson, EL; Solomon, SD; Granger, CB; Swedberg, K; Pfeffer, MA; Yusuf, S ...
Published in: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
2007

Duke Scholars

Published In

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

ISSN

0735-1097

Publication Date

2007

Volume

49

Issue

9

Start / End Page

61A / 61A

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
MacDonald, M. R., Varyani, F., Carlsson, J., Petrie, M., Ostergren, J., Michelson, E. L., … McMurray, J. J. (2007). Comparison of the risk associated with diabetes mellitus in patients with preserved and low ejection fraction heart failure: An analysis of the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) program. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (Vol. 49, pp. 61A-61A).
MacDonald, Michael R., Fumi Varyani, Jonas Carlsson, Mark Petrie, Jan Ostergren, Eric L. Michelson, Scott D. Solomon, et al. “Comparison of the risk associated with diabetes mellitus in patients with preserved and low ejection fraction heart failure: An analysis of the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) program.” In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 49:61A-61A, 2007.
MacDonald MR, Varyani F, Carlsson J, Petrie M, Ostergren J, Michelson EL, Solomon SD, Granger CB, Swedberg K, Pfeffer MA, Yusuf S, McMurray JJ. Comparison of the risk associated with diabetes mellitus in patients with preserved and low ejection fraction heart failure: An analysis of the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) program. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2007. p. 61A-61A.
Journal cover image

Published In

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

ISSN

0735-1097

Publication Date

2007

Volume

49

Issue

9

Start / End Page

61A / 61A

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1102 Cardiorespiratory Medicine and Haematology